Gw optimism, Blue negativsm, Rk neutralsm, We got all the folks together.
Gw, your are really suave, $100M in 3 years of marketing? and you expect it out in 2 years?, the truth is Allergan is a great marketeer, but this is way optimistic. I say 4 years to get to market, and 10 years to global sales (not just US)of $50M.
Blue, pseudomonas in some postoperative eye infections, especially the cornea that is poorly vascularized and antibiotics do not reach well, is an example of the kind o lesions one will imagine rbpieyeversion to theoretically be worth the money they will charge, but all those weird bugs from the amazon and congo jungles are no a way to market this Iprex thing. How many anacondas will need iprex after a frog spit on her eyes?
A big market could be prevention, Allergan will add bpi to all the contact lens cleaners, and to all the irritated eyes, but it could be that the manufacture plan can produce it for few dollars (those huge margins in Amgn, Dna, Bgen, Medi are not due to expensive manufacturing after all).
But, poor blue, he does not like bpi enhanced qualities!!!
The best deal will be to add it to Listerine/alcohol free version (to be hated by many, but churches), for sorethroat, this is one of those unmet medical needs, no antibiotic has being able to get patients to feel better, but the baboon king fast bug killer will be. At the time, Blue will be the Chief executioner officer of Amaxoma.org! |
